Tuesday, February 7, 2023
It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity, and scientific rigor. All persons involved in the selection, development, and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms: 1) altering the financial relationship with the commercial interest, 2) altering the individual's control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity.
Professor of Medicine
Director
AHA Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, Illinois
Associate Professor of Medicine
The George Institute for Global Health
Newtown, New South Wales, Australia
Editorial Board Member
ADA's "Clinical Diabetes"
Family Practice Physician
CaroMont Family Medicine
Gastonia, North Carolina
Associate Professor of Clinical Pharmacy
Chair, Division of Clinical Pharmacy
Director of Interprofessional Education and Simulation
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of California, San Diego
La Jolla, California
Project staff, meeting planners, planning committee, CME committee reviewers, and CME peer reviewers do not have any relevant financial relationships to disclose. The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California San Diego School of Medicine.
This activity is intended for primary care physicians, nephrologists, diabetologists and endocrinologists, nurses, nurse practitioners, and other health care professionals who treat patients with type 2 diabetes (T2D) and chronic kidney disease (CKD).
The goal of this activity is to improve awareness of newer uses of SGLT2 sodium-glucose cotransporter 2 (SGLT2) inhibitors.
Upon completion of this activity, participants will:
It is the policy of the University of California, San Diego School of Medicine to ensure balance, independence, objectivity, and scientific rigor. All persons involved in the selection, development, and presentation of content are required to disclose any real or apparent conflicts of interest. All conflicts of interest will be resolved prior to an educational activity being delivered to learners through one of the following mechanisms: 1) altering the financial relationship with the commercial interest, 2) altering the individual's control over CME content about the products or services of the commercial interest, and/or 3) validating the activity content through independent peer review. All persons are also required to disclose any discussions of off label/unapproved uses of drugs or devices. Persons who refuse or fail to disclose are disqualified from participating in the CME activity.
Professor of Medicine
Director
AHA Comprehensive Hypertension Center
University of Chicago Medicine
Chicago, Illinois
Associate Professor of Medicine
The George Institute for Global Health
Newtown, New South Wales, Australia
Editorial Board Member
ADA's "Clinical Diabetes"
Family Practice Physician
CaroMont Family Medicine
Gastonia, North Carolina
Associate Professor of Clinical Pharmacy
Chair, Division of Clinical Pharmacy
Director of Interprofessional Education and Simulation
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of California, San Diego
La Jolla, California
Project staff, meeting planners, planning committee, CME committee reviewers, and CME peer reviewers do not have any relevant financial relationships to disclose. The views and opinions expressed in this activity are those of the faculty and do not necessarily reflect the views of the University of California San Diego School of Medicine.
The University of California, San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of California, San Diego School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is in compliance with California Assembly Bill 1195 which requires CME courses with patient care components to include curriculum in the subjects of cultural and linguistic competencies. Cultural competency is defined as a set of integrated attitudes, knowledge, and skills that enables health care professionals or organizations to care effectively for patients from diverse cultures, groups, and communities. Linguistic competency is defined as the ability of a physician or surgeon to provide patients who do not speak English or have limited ability to speak English, direct communication in the patient's primary language. Cultural and linguistic competency was incorporated into the planning of this activity. Additional resources on cultural and linguistic competency and information about AB1195 can be found on the UC San Diego CME website at http://cme.ucsd.edu
Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 6/28/2019
Valid for credit through: 6/28/2020
processing....
Developed through a partnership between Medscape and University of California San Diego.
Disclaimer
The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.
Medscape Education © 2019
Regents of the University of California and Medscape, LLC with permission
